Related references
Note: Only part of the references are listed.MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease
Dan Wang et al.
CURRENT NEUROVASCULAR RESEARCH (2020)
Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3
Youri Oh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
Xiaodong Dou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods
Ghada Omar Tuffaha et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Multistage Screening Reveals 3-Substituted lndolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases
Xiaodong Dou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors
Hoyong Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline
Sarah Gourmaud et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) Inhibitors
Ke Zheng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Structural Basis and Biological Consequences for JNK2/3 Isoform Selective Aminopyrazoles
HaJeung Park et al.
SCIENTIFIC REPORTS (2015)
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
Ke Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Potent and Selective Covalent Inhibitors of JNK
Tinghu Zhang et al.
CHEMISTRY & BIOLOGY (2012)
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Sung Ok Yoon et al.
NEURON (2012)
JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
Candice E. Crocker et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment
Luisa de Lemos et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin
Gerardo A. Morfini et al.
NATURE NEUROSCIENCE (2009)
JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration
Vincent Ries et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold
PP Graczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease
S Hunot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A critical role of neural-specific JNK3 for ischemic apoptosis
CY Kuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeting JNK for therapeutic benefit: From JuNK to gold?
AM Manning et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells
H Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand
Y Morishima et al.
JOURNAL OF NEUROSCIENCE (2001)
Share Paper
